![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference PR Newswire SAN DIEGO, Aug. 7, 2024 SAN DIEGO, Aug. 7, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc...
Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance PR Newswire SAN DIEGO, Aug. 1, 2024 INGREZZA® (valbenazine) Second Quarter Net Product...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 65.98 | 1.77192209773 | 3723.64 | 3795.66 | 3579.79 | 0 | 0 | IX |
4 | 43.46 | 1.16012129754 | 3746.16 | 3795.66 | 3579.79 | 0 | 0 | IX |
12 | 21.72 | 0.576448419544 | 3767.9 | 3795.66 | 3474.79 | 0 | 0 | IX |
26 | -76.53 | -1.97948863857 | 3866.15 | 3954.99 | 3474.79 | 0 | 0 | IX |
52 | 143.43 | 3.93369517222 | 3646.19 | 4020.42 | 3411.87 | 0 | 0 | IX |
156 | -788.03 | -17.214728081 | 4577.65 | 4603.85 | 3113.01 | 0 | 0 | IX |
260 | -243.93 | -6.04752637255 | 4033.55 | 4886.74 | 2388.58 | 0 | 0 | IX |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions